UNSPSC 51282954: Enoxacin sesquihydrate

This classification denotes an anti-infective agent 2C15H17FN4O3.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I9CD31N8WB, chemically known as 1,8-naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrate (2:3), but more generally known as enoxacin sesquihydrate, which bears US NIH Compound Identifier 3229. European Medicines Agency schedules SUB13675MIGin its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13675MIG.

Most nations schedule enoxacin sesquihydrate under HS 29335995 and SITC 51576. As of Q4 2014, ENOXACIN SESQUIHYDRATE remains the US FDA Preferred Term for this commodity. SMILES: CCN1CC(C(=O)C2C1NC(C(C2)F)N3CCNCC3)C(=O)O.CCN1CC(C(=O)C2C1NC(C(C2)F)N3CCNCC3)C(=O)O.O.O.O.

UNSPSC 51282954 Enoxacin sesquihydrate is a Commodity code that nominally designates a specific pharmaceutical product, but recent state and local procurement activity shows minimal direct sourcing of this compound. Instead, the code's recent solicitations reflect broader pharmaceutical and medical supply procurement across health and safety agencies — including naloxone, generic multi-source pharmaceuticals, over-the-counter products, and emergency medical supplies. The issuing bodies soliciting under or near this code include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire rescue divisions (City of Tampa), and multistate cooperative purchasing consortiums (Minnesota Multistate Cooperative Purchasing Alliance). Work being solicited ranges from naloxone and drug deactivation systems for community health initiatives to emergency medical and first aid supplies for rescue operations, to large-scale generic pharmaceutical contracting across multiple government jurisdictions.

Recent activity spans Florida, Texas, Minnesota, and Oregon, with the most substantial current opportunity in the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (Solicitation S1070000015802, due March 26, 2026), which established contracts effective July 1, 2026 across participating state and local facilities. The City of Tampa released an IFB for medical and first aid supplies for the Tampa Fire Department Rescue Division (Solicitation 26P00145, due March 13, 2026, estimated contract value $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises). Seminole County, Florida solicited naloxone and drug deactivation systems through competitive bidding (Solicitation IFB60459723LAS, due July 26, 2023), with quarterly deliveries to county health facilities. The Texas HHS Commission issued a Request for Information on Direct-to-Manufacturer Prescriptions (Solicitation HHS0017013, response due April 3, 2026) to gather market intelligence on establishing direct relationships between the state pharmacy benefit program and manufacturers. The code shows fragmented but active procurement across health, emergency response, and pharmacy benefit administration rather than concentrated demand for enoxacin sesquihydrate as a specific input.